Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05828927 · ClinicalTrials.gov registry record · NA

enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers

A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
111
Enrollment target

NCT05828927: Completed NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT05828927 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05828927, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
111 participants
Enrollment target

Study Summary

This study explores the feasibility, acceptability, and preliminary efficacy of a social support intervention in cancer caregivers who live in rural communities. Cancer caregivers need support, especially when they live at a distance from healthcare centers. enCompass Carolina is a social support intervention, that supports caregivers by helping them find and use new sources of support. The purpose of this study is to test and receive feedback about the program.

Primary Outcome

Study feasibility will be measured by caregiver enrollment rates, defined as the proportion of eligible caregivers approached about the study who consent to participate.

Interventions

  • BEHAVIORAL Eco-mapping tool
  • BEHAVIORAL Caregiver-coach study visits

Trial Details

FieldValue
Enrollment Target 111 participants
Start Date 2023-05-15
Est. Completion 2024-06-24
Phase NA

What the finished NCT05828927 record still lists

NCT05828927 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Eco-mapping tool is the first listed.

NCT05828927 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05828927 about?

NCT05828927 is a clinical study titled "enCompass Carolina: A Social Support and Coaching Program for Cancer Caregivers". This study explores the feasibility, acceptability, and preliminary efficacy of a social support intervention in cancer caregivers who live in rural communities. Cancer caregivers need support, especially when they live at a distance from healthcare centers. enCompass Carolina is a social support in...

What is the current status of trial NCT05828927?

This trial is currently completed. It is a NA study. The enrollment target is 111 participants. The study started on 2023-05-15. Estimated completion is 2024-06-24.

What interventions are being tested in trial NCT05828927?

The interventions under investigation include: Eco-mapping tool (BEHAVIORAL), Caregiver-coach study visits (BEHAVIORAL).

Who is sponsoring clinical trial NCT05828927?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05828927's enrollment target sits among peer trials

111 816th of 2000 higher than 1,185 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03875716 · 111 participants · NA

    Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma

  • NCT04693468 · 111 participants · Phase 1

    Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial

  • NCT05263050 · 111 participants · Phase 2

    Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors

  • NCT05600842 · 111 participants

    De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05828927, the US trial registry maintained by the National Library of Medicine. NCT05828927 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.